Infection, cancer and prevention: report of the 19th International Symposium of the Foundation for Promotion of Cancer Research.
暂无分享,去创建一个
Martin J Blaser | Daizo Saito | Tadao Kakizoe | M. Blaser | T. Kakizoe | F. Emura | D. Saito | Fabian Emura
[1] M. Hatakeyama. Oncogenic mechanisms of the Helicobacter pylori CagA protein , 2004, Nature Reviews Cancer.
[2] S. Kamiya,et al. Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice. , 2000, Journal of medical microbiology.
[3] T. Liang,et al. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Hakama,et al. Report of the Thirteenth International Symposium of the Foundation for Promotion of Cancer Research: cancer screening-past, present and future. , 2000, Japanese journal of clinical oncology.
[5] M Fujita,et al. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Blaser,et al. Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.
[7] K. Takada,et al. Phosphatidylinositol 3-Kinase Is a Determinant of Responsiveness to B Cell Antigen Receptor-Mediated Epstein-Barr Virus Activation1 , 2004, The Journal of Immunology.
[8] M. Blaser,et al. Helicobacter pylori persistence: biology and disease. , 2004, The Journal of clinical investigation.
[9] R. Jacobson,et al. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. , 2004, The New England journal of medicine.
[10] T. Kanda,et al. Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation , 2005, Journal of Virology.
[11] M. Alter,et al. Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.
[12] T. Sugiyama,et al. Melanoidin, a Food Protein‐Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo , 2004, Helicobacter.
[13] M. Alter,et al. Epidemiology of hepatitis B in Europe and worldwide. , 2003, Journal of hepatology.
[14] M. V. Doeberitz. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. , 2002 .
[15] M. Blaser,et al. Dynamics of Helicobacter pylori colonization in relation to the host response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] Martin J Blaser,et al. Bacterial biota in the human distal esophagus , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Jacobson,et al. Prevention of Hepatitis B with the Hepatitis B Vaccine , 2004 .
[18] H. Maeda,et al. Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH. , 1999, Cancer letters.
[19] J. Lee,et al. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.